HKG Equity Snapshot
2171 Weekly Equity Report
CARsgen Therapeutics Holdings Limited
What the company does
CARsgen Therapeutics Holdings Limited, an investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China. The company's products include Zevor-cel (CT053) for the treatment of relapsed/refractory multiple myeloma. It is also developing autologous CAR-T product candidates, including CT041, which targets Claudin 18.2, is in phase II/III clinical trial for gastric/gastroesophageal junction cancer and pancreatic cancer, as well as in phase I clinical trial for gastric or pancreatic cancer; CT011, which is in phase I clinical trial …
What the weekly tape is saying
2171 closed the latest completed week at 15.02 HKD. The 4-week return is -23.8% and the 12-week return is -1.2%. Trend Signal is inactive, Market Dynamics is -0.00. Setup signature: Risk-first tape with a 20/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 17.10 HKD
- Vs Trend Line
- -12.2%
- Fair Value
- 11.88 HKD
- Vs Fair Value
- 26.5%
- 52W High
- 28.60 HKD
- 52W Low
- 10.87 HKD
- Drawdown
- -47.5%
- Range Position
- 23.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 23
- 52W Active Breadth
- 44.2%
- Sector Scope
- HK Healthcare
- Sector Rank
- 224 of 257
- Sector Percentile
- 12.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 87 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 55 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.00
- 4W MD Change
- -100.4%
- Relative Strength
- -15.63
- 4W RS Change
- -603.6%
- Expectation
- Undecided
- Probability
- 51.72%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 35.6M
- 13W Average
- 28.8M
- 52W Average
- 16.2M
- Vs 13W
- 1.2x
- Vs 52W
- 2.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 13.4%
- 52W Volatility
- 11.5%
- Upside Weeks
- 24
- Downside Weeks
- 28
- Downside Breadth
- 53.8%
- Avg Gain / Loss
- 8.4% / -7.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 9.9B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 15.02 HKD | -8.0% | 17.10 HKD | 11.88 HKD | -0.00 | -15.63 | 35.6M | Off |
| 5 Jun 2026 | 16.32 HKD | -9.9% | 17.20 HKD | 11.85 HKD | 0.35 | -10.11 | 26.3M | On |
| 29 May 2026 | 18.11 HKD | 3.4% | 17.18 HKD | 11.81 HKD | 0.70 | -1.52 | 21.6M | On |
| 22 May 2026 | 17.51 HKD | -11.2% | 17.13 HKD | 11.76 HKD | 0.95 | -6.74 | 29.7M | On |
| 15 May 2026 | 19.72 HKD | -15.3% | 17.09 HKD | 11.72 HKD | 1.30 | 3.10 | 65.0M | On |
| 8 May 2026 | 23.28 HKD | 7.8% | 16.97 HKD | 11.67 HKD | 1.45 | 19.52 | 21.1M | On |
| 1 May 2026 | 21.60 HKD | -12.6% | 16.79 HKD | 11.59 HKD | 1.41 | 13.97 | 17.2M | On |
| 24 Apr 2026 | 24.70 HKD | -0.8% | 16.70 HKD | 11.53 HKD | 1.47 | 29.76 | 39.0M | On |
| 17 Apr 2026 | 24.90 HKD | 36.5% | 16.49 HKD | 11.45 HKD | 1.32 | 30.76 | 34.7M | Off |
| 10 Apr 2026 | 18.24 HKD | -0.8% | 16.37 HKD | 11.38 HKD | 0.98 | -2.31 | 9.7M | Off |
| 3 Apr 2026 | 18.39 HKD | 5.3% | 16.44 HKD | 11.36 HKD | 0.81 | 1.87 | 22.7M | Off |
| 27 Mar 2026 | 17.46 HKD | 14.9% | 16.60 HKD | 11.32 HKD | 0.27 | -2.41 | 28.0M | Off |
| 20 Mar 2026 | 15.20 HKD | -1.7% | 16.78 HKD | 11.29 HKD | -0.15 | -16.07 | 24.2M | Off |
| 13 Mar 2026 | 15.46 HKD | 42.2% | 16.98 HKD | 11.28 HKD | -0.35 | -15.10 | 83.2M | Off |